AL
ISEE

AJO LP’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

AJO LP’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,088,572
Closed -$2.57M – 737
2018
Q3 		$2.57M Sell
1,088,572
-384,535
-26% -$958K 0.01% 438
2018
Q2 		$4.02M Buy
1,473,107
+142,197
+11% +$392K 0.02% 378
2018
Q1 		$3.65M Buy
1,330,910
+601,465
+82% +$1.74M 0.02% 384
2017
Q4 		$2.28M Buy
+729,445
New +$2.05M 0.01% 421

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AJO LP's ISEE Position: Q4 2018 in Review

AJO LP sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2018, closing a stake of 1,088,572 shares — an estimated $2.57M sold.

AJO LP first reported a position in ISEE in Q4 2017 and held it in 4 quarters. The position peaked at $4.02M in Q2 2018. 63 funds tracked by Wall St. Rank hold ISEE as of Q4 2018.

  • AJO LP reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • AJO LP sold 1,088,572 IVERIC bio, Inc. Common Stock shares in Q4 2018, an estimated $2.57M.
  • AJO LP first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 4 quarters.
  • AJO LP's IVERIC bio, Inc. Common Stock position peaked at $4.02M in Q2 2018.
  • 63 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2018.

Based on AJO LP's 13F filing for Q4 2018, filed 13 Feb 2019.